Free Trial
NASDAQ:MGRX

Mangoceuticals Q1 2024 Earnings Report

Mangoceuticals logo
$2.25 +0.29 (+14.80%)
Closing price 04:00 PM Eastern
Extended Trading
$2.26 +0.00 (+0.22%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mangoceuticals EPS Results

Actual EPS
-$22.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mangoceuticals Revenue Results

Actual Revenue
$0.21 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mangoceuticals Announcement Details

Quarter
Q1 2024
Time
N/A
Conference Call Date
Wednesday, May 15, 2024
Conference Call Time
6:00PM ET

Earnings Documents

Mangoceuticals Earnings Headlines

Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Update
Mangoceuticals (NASDAQ:MGRX) Raised to "Hold" at Wall Street Zen
What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
Mangoceuticals President Tony Isaac Resigns
See More Mangoceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mangoceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mangoceuticals and other key companies, straight to your email.

About Mangoceuticals

Mangoceuticals (NASDAQ:MGRX) develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

View Mangoceuticals Profile

More Earnings Resources from MarketBeat